HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 194 filers reported holding HAEMONETICS CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,931,891 | +17.6% | 431,429 | +10.6% | 0.01% | 0.0% |
| Q3 2022 | $28,865,037 | +15.2% | 389,910 | +1.5% | 0.01% | +33.3% |
| Q2 2022 | $25,049,000 | +3.8% | 384,305 | +0.7% | 0.01% | +20.0% |
| Q1 2022 | $24,135,563 | +19.2% | 381,771 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $20,249,000 | -25.0% | 381,771 | -0.2% | 0.00% | -33.3% |
| Q3 2021 | $26,998,000 | -18.0% | 382,465 | -22.6% | 0.01% | -14.3% |
| Q2 2021 | $32,941,000 | -31.1% | 494,309 | +14.8% | 0.01% | -36.4% |
| Q1 2021 | $47,781,000 | -20.1% | 430,417 | -14.5% | 0.01% | -21.4% |
| Q4 2020 | $59,775,000 | +32.3% | 503,369 | -2.8% | 0.01% | +16.7% |
| Q3 2020 | $45,175,000 | -15.4% | 517,767 | -13.2% | 0.01% | -20.0% |
| Q2 2020 | $53,399,000 | -25.8% | 596,236 | -17.4% | 0.02% | -42.3% |
| Q1 2020 | $71,960,000 | -13.3% | 722,059 | 0.0% | 0.03% | +13.0% |
| Q4 2019 | $82,965,000 | -15.7% | 722,059 | -7.5% | 0.02% | -23.3% |
| Q3 2019 | $98,456,000 | +4.8% | 780,522 | 0.0% | 0.03% | +3.4% |
| Q2 2019 | $93,928,000 | +33.6% | 780,522 | -2.9% | 0.03% | +26.1% |
| Q1 2019 | $70,307,000 | -12.6% | 803,702 | 0.0% | 0.02% | -23.3% |
| Q4 2018 | $80,411,000 | -12.7% | 803,702 | 0.0% | 0.03% | 0.0% |
| Q3 2018 | $92,088,000 | +22.1% | 803,702 | -4.4% | 0.03% | +15.4% |
| Q2 2018 | $75,398,000 | +8.1% | 840,740 | -11.8% | 0.03% | +4.0% |
| Q1 2018 | $69,749,000 | +26.0% | 953,373 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $55,372,000 | +26.8% | 953,373 | -2.0% | 0.02% | +17.6% |
| Q3 2017 | $43,668,000 | +28.1% | 973,213 | +12.8% | 0.02% | +21.4% |
| Q2 2017 | $34,085,000 | +64.7% | 863,124 | +69.2% | 0.01% | +75.0% |
| Q1 2017 | $20,701,000 | +0.9% | 510,245 | 0.0% | 0.01% | -11.1% |
| Q4 2016 | $20,512,000 | +58.4% | 510,245 | +36.3% | 0.01% | +50.0% |
| Q3 2016 | $12,951,000 | -4.4% | 374,477 | -19.9% | 0.01% | 0.0% |
| Q2 2016 | $13,550,000 | -15.3% | 467,417 | +2.2% | 0.01% | -25.0% |
| Q1 2016 | $16,004,000 | +8.5% | 457,517 | 0.0% | 0.01% | +14.3% |
| Q4 2015 | $14,750,000 | -10.6% | 457,517 | -10.3% | 0.01% | -22.2% |
| Q3 2015 | $16,492,000 | -21.9% | 510,259 | 0.0% | 0.01% | -18.2% |
| Q2 2015 | $21,104,000 | -7.9% | 510,259 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $22,921,000 | +27.8% | 510,259 | +6.5% | 0.01% | +22.2% |
| Q4 2014 | $17,934,000 | +7.2% | 479,266 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $16,736,000 | -36.2% | 479,266 | -35.5% | 0.01% | +28.6% |
| Q2 2014 | $26,220,000 | +116.5% | 743,168 | +100.0% | 0.01% | 0.0% |
| Q1 2014 | $12,110,000 | -22.6% | 371,584 | 0.0% | 0.01% | -22.2% |
| Q4 2013 | $15,655,000 | +5.6% | 371,584 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $14,818,000 | +57.7% | 371,584 | +63.5% | 0.01% | +50.0% |
| Q2 2013 | $9,398,000 | +27.0% | 227,279 | +28.0% | 0.01% | +20.0% |
| Q1 2013 | $7,399,000 | +3.9% | 177,614 | +100.0% | 0.01% | 0.0% |
| Q3 2012 | $7,122,000 | -2.8% | 88,807 | -12.9% | 0.01% | -16.7% |
| Q2 2012 | $7,330,000 | – | 101,930 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |